Work

Vismodegib in the treatment of patients with metastatic basal cell carcinoma (mBCC) and distant metastases: Survival in the pivotal phase II and phase I studies.

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.15_suppl.9012

Authors: Karl D. Lewis, Aleksandar Sekulic, Axel Hauschild, Michael Robert Migden, Anthony E. Oro, Patricia LoRusso, Charles M. Rudin, Luc Dirix, James A. Solomon, John D. Hainsworth, Sarah Williams, Jeannie Hou, Daniel D. Von Hoff

Institutions: University of Colorado Cancer Center, Mayo Clinic, Mayo Clinic in Arizona, University Hospital Schleswig-Holstein, The University of Texas MD Anderson Cancer Center, Stanford Medicine, Stanford University, Wayne State University, The Barbara Ann Karmanos Cancer Institute, Memorial Sloan Kettering Cancer Center, Sarah Cannon, Genentech, Translational Genomics Research Institute

Language: English

Topic: Nonmelanoma Skin Cancer Studies

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2309900949

Cites:

Cited by: 5

Related to: 10